CCEL vs T · P/E 490, $39.6M cap vs P/E 7.4, rev $125.65B
CryoCell International Inc (CCEL) versus AT&T Inc. (T) — a side-by-side from cached financials, not a winner call.
CryoCell International Inc (CCEL) is a medical care facilities company listed on US.
AT&T Inc. (T) is a telecom services company listed on NYSE. It is led by John Stankey.
CCEL does not have a complete income-statement cache yet.
Latest reported T revenue for 2025-12-31 was $125.65B. Net income was $21.95B. Revenue was up 2.7% from 2024-12-31 to 2025-12-31. T currently screens at market cap $155.92B and trailing P/E 7.4.
CCEL currently screens at market cap $39.6M and trailing P/E 490.0. T currently screens at market cap $155.92B and trailing P/E 7.4.
Not investment advice. Open the CCEL and T stock pages for the full models.
Not investment advice.